Is Elevated Norepinephrine an Etiological Factor in Some Cases of Alzheimer's Disease?

E-ISSN： 1875-5828|7|6|506-516

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.7, Iss.6, 2010-09, pp. : 506-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nerve Growth Factor Gene Therapy for Alzheimer's Disease

By Tuszynski M.H. Thal L. U H-S. Pay M.M. Blesch A. Conner J. Vahlsing H.L.

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 207-208

Humana Press, Inc

Access to resources Recommend Favorite

Cystathionine Beta Synthase as a Risk Factor for Alzheimer Disease

Current Alzheimer Research, Vol. 1, Iss. 2, 2004-05 ,pp. : 127-133

Bentham Science Publishers

Access to resources Recommend Favorite

The Spanish School of Neurology and the First American Cases of Alzheimer's Disease

By García-Albea E. Trullen J.M. Pérez

Journal of the History of the Neurosciences, Vol. 12, Iss. 4, 2003-12 ,pp. : 437-445

Taylor & Francis Ltd

Access to resources Recommend Favorite

Is hemochromatosis a risk factor for Alzheimer's disease?

By Connor J.R.

Journal of Alzheimer's Disease, Vol. 3, Iss. 5, 2001-01 ,pp. : 471-477

Ios Press

Access to resources Recommend Favorite

On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer’s Disease

By Capsoni Simona Cattaneo Antonino

Cellular and Molecular Neurobiology, Vol. 26, Iss. 4-6, 2006-07 ,pp. : 617-631

Springer Publishing Company

Access to resources Recommend Favorite